President & Immunovant CEO · Roivant Sciences Ltd. · Common Shares
Side
SELL
Value
$501K
Shares
14.1K
Price
$35.42
Executed
Oct 20, 2026
Disclosed
Oct 22, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Oct 20 executedOct 22, 2026 disclosed
ROIV · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Venker Eric filed this Form 4 reporting a open-market sale of ROIV on Oct 20, 2026. It became public on Oct 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
President & Immunovant CEO
Venker Ericcik:0001801917
Issuer
Roivant Sciences Ltd.cik:0001635088
Revision history · 0
No field has changed since this record was first ingested.
